Related Experiment Video
Updated: Sep 4, 2025
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.3K
[ACUTE MYOCARDIAL INFARCTION FOLLOWING COVID-19]
Vladimir Poletaev1, Dante Antonelli1, Ehud Rozner1
1Department of Cardiology, Ha'Emek Medical Center, Afula, Israel.
Harefuah
|July 14, 2022
Summary
A young woman developed acute ST elevation myocardial infarction (STEMI) after COVID-19 infection. This case highlights COVID-19 as a potential trigger for heart attack in young individuals, even without traditional risk factors.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- A 30-year-old woman experienced COVID-19 followed by chest pain.
- Initial diagnosis considered myocarditis, but acute ST elevation myocardial infarction (STEMI) was confirmed.
Purpose of the Study:
- To report a case of STEMI in a young patient post-COVID-19.
- To investigate the potential link between COVID-19 infection and myocardial infarction in young adults.
Main Methods:
- Clinical presentation and diagnosis of STEMI.
- Coronary angiography and successful stenting of the left anterior descending (LAD) artery.
- Echocardiography assessment at 6-month follow-up.
Main Results:
- The patient underwent successful stenting of the LAD artery.
- At 6 months, clinical condition improved with Left Ventricular Ejection Fraction (LVEF) of 45%.
Conclusions:
- COVID-19 infection can precipitate STEMI in young individuals.
- This case underscores the importance of considering cardiovascular complications post-COVID-19, even in the absence of risk factors.
Related Concept Videos
01:14Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
01:21Myocarditis I: Introduction
25
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25
01:30Acute Coronary Syndrome I: Introduction
70
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
70
01:27Myocarditis II: Clinical Features and Diagnostic Tests
20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
01:28Acute Coronary Syndrome IV: Interprofessional Care
24
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
43
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
43